Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Right-handed ibuprofen vs ibuprofen suspension for fever in pediatric acute respiratory infections
ChiCTR2600116566Phase 4Not yet recruiting
- Sponsor
- Hangzhou First People's Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexibuprofen in acute respiratory illness (ARI) and fever (2 arms), sponsored by Hangzhou First People's Hospital. Primary endpoint: Temperature change 4 hours after administration. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
dexibuprofen
03
Conditions
acute respiratory illness (ARI)fever
Beyond the preview
Go deeper on ChiCTR2600116566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116566.